Mercaptoimidazoles as CCR2 receptor antagonists

Details for Australian Patent Application No. 2005250156 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Doyon, Julien Georges Pierre-Olivier; Coesemans, Erwin; Van Lommen, Guy Rosalia Eugeen; Boeckx, Gustaaf Maria

Agent Shelston IP

Pub. Number AU-A-2005250156

PCT Pub. Number WO2005/118578

Priority PCT/ EP2004/050933 26.05.04 EP

Filing date 24 May 2005

Wipo publication date 15 December 2005

International Classifications

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/118578 Priority application(s): WO2005/118578

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005250157-Mercaptoimidazoles as CCR2 receptor antagonists

2005250155-Polyurethane containing a polyol composition comprising a highly branched polysaccharide, mix and process for preparation thereof